Press release
Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industry | Transdermal Skin Patches Market Research Report: Ken Research
According to the report analysis, ‘Transdermal Skin Patches Market Global Report 2020-30’ states that the worldwide transdermal skin patches market was worth USD 6.23 billion during 2019. It is predicted to augment at a compound annual growth rate (CAGR) of 4.50% and reach USD 0 billion by 2023. Rigorous regulatory authorization by the government regulatory bodies is a foremost aspect hindering the growth of the transdermal skin patches market. The regulatory authority administers the laws regulating biologics, medications, and medical devices, which can have probable side effects for customers. For instance, Food and Drug Administration (FDA) instructions the TDDS to undergo series of tests comprising biomechanical testing, animal testing, and clinical trials before admiring the TDDS for utilize in the market. The whole procedure consumes time and may result in interruption for establish of TDDS into the market mislaying the first-mover advantage thus limiting the growth of the transdermal skin patch market.
Moreover, the major corporates in the market are increasingly choosing for acquisitions and collaborations to augment and expand their footprint for the growth of the transdermal skin patches market. The strategic merger and acquisition and collaboration shadowed by the players in the transdermal skin patches market enables the companies to take technological benefit by obtaining the technology which enables them to get ahead in the competition. For instance, during 2019, Canoa Inc., a Delaware based healthcare and pharmaceuticals company, obtained ProSolus Inc. to improve its position and improvement of fresh products in transdermal space. ProSolus headquartered around the USA is a pharmaceutical company that delivers the transdermal solutions.
Similarly, during 2019, Mylan, a pharmaceutical company delivering transdermal skin patches, with Upjohn, a subsidiary of Pfizer broadcast the formation of a fresh company named Viatris. The focus of the fresh collaboration is to deliver more innovative medicines to the patients worldwide. Pfizer is a multinational pharmaceutical company. Thus, corporates functioning in the transdermal skin patch market are succeeding the strategic collaborations and acquisitions to have a competitive edge.
In addition, the advances in the modern technologies underwrites to the growth of transdermal skin patches market. Advances in modern technologies augment the number of drugs being provided transdermally involving small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules. The fresh technological advances add to the augmented efficiency and developed use of transdermal drug delivery systems (TDDS) thus, growing the popularity and requirement for TDDS. For instance, during 2019, few technological advances in the TDDS included transdermal patch formulation enhancement, introduction of pressure-sensitive adhesives and permeation enhancers, which lead to augmented product diffusion and developed drug retention capability in larger quantities. The advances in technologies are projected to augment the requirement for transdermal patches due to its benefits thereby propelling the growth of the market. Therefore, in the coming years, it is predicted that the market of transdermal skin patched will increase around the globe more effectively.
For More Information, Click on the Link Below:-
https://www.kenresearch.com/healthcare/pharmaceuticals/transdermal-skin-patches/342057-91.html
Related Report:-
https://www.kenresearch.com/healthcare/pharmaceuticals/transdermal-skin-patches/387806-91.html
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India
Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industry | Transdermal Skin Patches Market Research Report: Ken Research here
News-ID: 2229860 • Views: 681
More Releases from Ken Research Pvt Ltd

Global Eubiotics Market is expected to reach ~USD 8 Bn by 2028F: Ken Research
Global Eubiotics Market By Geography
The Global Eubiotics market is segmented by geography into North America, Europe, Asia- pacific and LAMEA.
Europe held the largest market share in 2022, because of the region's strict rules and regulations that forbid the use of antibiotics, the existence of major market players, and awareness of the use of Eubiotics and their advantages.
This is due to rising animal output and meat consumption, which comes from processed foods.…

Cybersecurity Market Revenues Growing at CAGR of 17.4%, Will Vietnam able to sus …
About 66% of Vietnam's 70k+ websites are estimated to be infected with viruses/malware. The government is playing a vibrant role in propagating the importance of having a secure cybersecurity infrastructure in organizations.
1. Cyberattacks have a huge financial impact on Vietnam's economy
Click to Read Full Article: Vietnam Cybersecurity Market: https://www.kenresearch.com/defense-and-security/security-devices/vietnam-cybersecurity-market-outlook-to-2025/419415-16.html
3% Companies in Vietnam that faced 24 hrs. or more of downtime after most severe breach; Global figure: 4%
2% Proportion of computers…

Every year over 30 Mn College Going Students require skill development to be Job …
India Career Skilling industry, which is growing at unprecedented rate as there is a clear expectation mismatch from Employer and Students even after attending higher education.
1. Every year 9.2 Mn students graduate from colleges, majority of them are looking for formal job but only some are able to secure one
Lack of tie ups / employers hinder job opportunities of tier 2, 3 and 4 colleges with placement Agencies
Lack of course…

Global Grease market revenue to reach US$ 7 Bn by 2028: Ken Research
Global Grease Market By Geography
The Global Grease market is segmented by geography into North America, Europe, Asia- pacific and LAMEA.
The Asia Pacific accounted for the largest market share within the global grease market, accounting major chunk of total market revenue in 2022 as it houses most of the lubricating companies.
According to the Indian Brand Equity Foundation (IBEF), a semi-government trust formulated by the department of commerce. Mentioned that an investment…
More Releases for Transdermal
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the…
Transdermal Drug Delivery System Market 2017 -
Apex Research, recently published a detailed market research study focused on the "Transdermal Drug Delivery System Market" across the global, regional and country level. The report provides 360° analysis of "Transdermal Drug Delivery System Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Transdermal Drug Delivery System industry, and estimates the future…
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Transdermal Patch
2. Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
3. Why There Exist Need for Transdermal Patches?
4. Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of…
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Transdermal Patch
Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
Why There Exist Need for Transdermal Patches?
Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3…
Transdermal Patch Market & Pipeline Insight 2015
Technological progress is continuously increasing allowing pharmaceutical companies to develop newer products with higher pharmacological benefits. Transdermal patches are extension of their continuous efforts due to which several patients have been able to improve quality of life. This market segment has yet to be tapped as only few disease indications are being covered under their treatment. Pharmaceutical companies are increasing their investments in research and development segment to introduce novel…